News

Deal Announcements

Chiasma Collects $3 Million Venture Capital Debt

Monday, June 11, 2012 5:54:00 AM PDT | VentureDeal
   Jerusalem, Israel  --  Pharmaceutical company Chiasma has garnered $3 million in new venture capital debt, according to an SEC filing.

Chiasma is developing solutions for noninvasive delivery of protein drugs, i.e., without the need for injections.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1